Earlier this month, London got a new member of its FTSE100 index, as GlaxoSmithKline split, amoeba-like, its non-drugs business from the pharmaceuticals.
Share this post
GlaxoSmithKline split: a parable for Britain…
Share this post
Earlier this month, London got a new member of its FTSE100 index, as GlaxoSmithKline split, amoeba-like, its non-drugs business from the pharmaceuticals.